Slater Technology Fund invests $500K in MindImmune Therapeutics

MindImmune Therapeutics is a South Kingstown-based pharmaceutical startup./ LOGO COURTESY MINDIMMUNE
MindImmune Therapeutics is a South Kingstown-based pharmaceutical startup.
PROVIDENCE – MindImmune Therapeutics Inc. will receive $500,000 in seed funding from Slater Technology Fund to support the drug discovery venture’s launch. MindImmune Therapeutics is treating central nervous system diseases such as Alzheimer’s and Huntington’s disease, as well as pain and psychiatric disorders, by developing drugs targeting the immune system. “Research advances over the past…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -